[Skip to Navigation]
Comment & Response
March 2018

Necessary Clarifications Concerning Results of the SUMMIT Trial

Author Affiliations
  • 1Kaiser Permanente Washington Health Research Institute, Seattle
  • 2VA Puget Sound Health Care System, Health Services Research & Development, Center of Innovation for Veteran Centered and Value Driven Care, Seattle, Washington
JAMA Intern Med. 2018;178(3):428-429. doi:10.1001/jamainternmed.2017.8356

To the Editor In an Original Investigation published in a recent issue of JAMA Internal Medicine, Watkins and colleagues1 conducted an important trial of collaborative care for primary care patients with probable alcohol and/or opioid use disorders (AUDs and/or OUDs). Considering a previous negative trial2 of primary care management for patients with AUDs and/or other drug use disorders,2 the SUMMIT trial1 is exciting because it suggests that 6 sessions of behavioral therapy, offered in primary care, could increase abstinence from alcohol and/or opioid use in patients with probable AUDs and/or OUDs. These results are very promising for guiding future clinical care and research. However, there are 2 areas in which the trial report1 lacks specificity for interpreting and applying results.

Add or change institution